Monday, June 15, 2026

Is This the End for Park Sang-yong? Legal Battle Looms Over North Korean Remittance Case

Prosecutor Park Sang-yong is suspended amid allegations of coercion in the North Korea remittance case, claiming political motivations behind the action.

AI Can Now Distinguish Dogs and Cats—Google Unveils Image AI Vision Banana

Google DeepMind's Vision Banana AI model excels in distinguishing objects, showcasing advanced visual analysis and generative capabilities.

Hyundai and Kia Are Now the Safest Cars on the Road—Again

Hyundai Motor Group maintains its global safety leadership with 15 models earning top safety ratings, including Elantra and Sonata.

Tag: Medipost

CARTISTEM vs. Traditional Treatments: What Makes Medipost’s Stem Cell Therapy a Game-Changer?

Medipost to commercialize CARTISTEM in Japan using domestically produced media, enhancing supply chain stability and competitiveness.

Medipost Reports Positive Phase 3 Results for CARTISTEM in Japan’s Knee Osteoarthritis Trial

Medipost's CARTISTEM therapy shows significant efficacy in Phase 3 trials for knee osteoarthritis in Japan, enhancing global competitiveness.

Medipost’s CARTISTEM® Completes Phase 3 Trials in Japan: What This Means for Knee Osteoarthritis Treatment

Medipost completes Phase 3 trial for CARTISTEM in Japan, targeting knee osteoarthritis treatment and planning U.S. trial enrollment soon.

Medipost’s Cartistem: Achieving 3000 Knee Cartilage Restoration Surgeries – A Game Changer for Osteoarthritis Treatment

Medipost's Cartistem therapy reaches 3,000 procedures for cartilage restoration, proving its safety and efficacy for knee osteoarthritis.

U.S. Surgeons Get Hands-On With Korea’s Game-Changing Stem Cell Therapy

Medipost's Cartistem® training program for U.S. orthopedic specialists enhances global collaboration and prepares for Phase 3 trials.

Top News

- Our Sponsors Ad -

Follow us